Anthony P Conley Selected Research

Anthony P Conley Research Topics

Disease

35	Neoplasms (Cancer) 05/2024 - 09/2015
23	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 07/2008
6	Liposarcoma 02/2024 - 01/2013
5	Leiomyosarcoma 04/2024 - 01/2013
5	Synovial Sarcoma (Synovioma) 01/2022 - 01/2013
5	Melanoma (Melanoma, Malignant) 05/2019 - 12/2012
4	Chordoma 05/2024 - 01/2022
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2024 - 02/2011
3	Alveolar Soft Part Sarcoma 09/2023 - 01/2020
3	Chondrosarcoma 01/2023 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2013
2	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2018
2	Triple Negative Breast Neoplasms 01/2024 - 01/2023
2	Hemangiosarcoma (Angiosarcoma) 01/2022 - 01/2022
2	Neurofibrosarcoma (MPNST) 10/2021 - 01/2013
2	Testicular Neoplasms (Testicular Cancer) 05/2019 - 01/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2017 - 01/2013
1	Cholangiocarcinoma 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Body Weight (Weight, Body) 09/2023
1	Nausea 01/2023
1	Anemia 01/2023
1	Fatigue 01/2023
1	Leukopenia 01/2023
1	Neutropenia 01/2023
1	Rectal Neoplasms (Rectal Cancer) 09/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Disease Progression 01/2022
1	Colitis 01/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021
1	Coccidioidomycosis 01/2021
1	Necrosis 01/2020
1	Mobility Limitation (Difficulty Walking) 11/2019
1	Paresthesia (Dysesthesia) 11/2019
1	Hypesthesia (Numbness) 11/2019
1	Guillain-Barre Syndrome 11/2019
1	Carcinogenesis 08/2019
1	Mesenchymal Chondrosarcoma 01/2019

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2008
3	AntigensIBA 10/2021 - 01/2017
3	Ifosfamide FDA LinkGeneric 04/2021 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
2	NivolumabIBA 02/2024 - 01/2022
2	GenieIBA 11/2023 - 08/2019
2	Gemcitabine FDA Link 01/2023 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 11/2019
2	CytokinesIBA 01/2018 - 01/2018
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 05/2024
1	ErbB Receptors (EGF Receptor)IBA 05/2024
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2024
1	Ribonucleases (Ribonuclease)IBA 04/2024
1	ripretinibIBA 02/2024
1	avapritinibIBA 02/2024
1	IpilimumabIBA 02/2024
1	Janus Kinase 1IBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	Hormones (Hormone)IBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2024
1	atezolizumabIBA 09/2023
1	eribulin FDA Link 01/2023
1	selinexorIBA 01/2023
1	Exportin 1 ProteinIBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2023
1	dostarlimabIBA 09/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	bempegaldesleukinIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 10/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	alovudineIBA 02/2020
1	Transcription Factor 3IBA 01/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	entrectinibIBA 01/2020
1	ParaffinIBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	VemurafenibIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019

Therapy/Procedure

27	Therapeutics 05/2024 - 01/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 03/2012
7	Immunotherapy 01/2022 - 03/2012
3	Radiotherapy 05/2024 - 05/2022
2	Molecular Targeted Therapy 05/2024 - 01/2020
2	Neoadjuvant Therapy 02/2024 - 02/2020
2	Investigational Therapies (Experimental Therapy) 01/2023 - 01/2020
1	Combined Modality Therapy 10/2019